QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 12 February 2003
doi: 10.1242/jcs.00331

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.00331v1 116/7/1349    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davis, T. Articles by Kipling, D. Search for Related Content PubMed PubMed Citation Articles by Davis, T. Articles by Kipling, D. Social Bookmarking                         What's this?

Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms

¹ Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff, CF14 4XN, UK
² School of Pharmacy and Biomolecular Sciences, University of Brighton, Cockcroft Building, Lewes Road, Brighton, BN2 4GJ, UK

^* Author for correspondence (e-mail: kiplingd{at}cardiff.ac.uk)

Accepted 18 December 2002

Werner-syndrome fibroblasts have a reduced in vitro life span before entering replicative senescence. Although this has been thought to be causal in the accelerated ageing of this disease, controversy remains as to whether Werner syndrome is showing the acceleration of a normal cellular ageing mechanism or the occurrence of a novel Werner-syndrome-specific process. Here, we analyse the signalling pathways responsible for senescence in Werner-syndrome fibroblasts. Cultured Werner-syndrome (AG05229) fibroblasts senesced after 20 population doublings with most of the cells having a 2N content of DNA. This was associated with hypophosphorylated pRb and high levels of p16^Ink4a and p21^Waf1. Senescent AG05229 cells re-entered the cell cycle following microinjection of a p53-neutralizing antibody. Similarly, production of the human papilloma virus 16 E6 oncoprotein in presenescent AG05229 cells resulted in senescence being bypassed and extended cellular life span. Werner-syndrome fibroblasts expressing E6 did not proliferate indefinitely but reached a second proliferative lifespan barrier, termed M^int, that could be bypassed by forced production of telomerase in post-M1 E6-producing cells. The conclusions from these studies are that: (1) replicative senescence in Werner-syndrome fibroblasts is a telomere-induced p53-dependent event; and (2) the intermediate lifespan barrier M^int is also a telomere-induced event, although it appears to be independent of p53. Werner-syndrome fibroblasts resemble normal human fibroblasts for both these proliferative lifespan barriers, with the strong similarity between the signalling pathway linking telomeres to cell-cycle arrest in Werner-syndrome and normal fibroblasts providing further support for the defect in Werner syndrome causing the acceleration of a normal ageing mechanism.

Key words: Ageing, Cellular senescence, Oncoprotein, Microinjection, Telomerase

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. M. Brosh Jr and V. A. Bohr Human premature aging, DNA repair and RecQ helicases Nucleic Acids Res., December 3, 2007; 35(22): 7527 - 7544. [Abstract] [Full Text] [PDF]

				S. Sharma, D. J. Stumpo, A. S. Balajee, C. B. Bock, P. M. Lansdorp, R. M. Brosh Jr., and P. J. Blackshear RECQL, a Member of the RecQ Family of DNA Helicases, Suppresses Chromosomal Instability Mol. Cell. Biol., March 1, 2007; 27(5): 1784 - 1794. [Abstract] [Full Text] [PDF]

				M. S. Eller, X. Liao, S. Liu, K. Hanna, H. Backvall, P. L. Opresko, V. A. Bohr, and B. A. Gilchrest A role for WRN in telomere-based DNA damage responses PNAS, October 10, 2006; 103(41): 15073 - 15078. [Abstract] [Full Text] [PDF]

				T. Davis, D. M. Baird, M. F. Haughton, C. J. Jones, and D. Kipling Prevention of Accelerated Cell Aging in Werner Syndrome Using a p38 Mitogen-Activated Protein Kinase Inhibitor J Gerontol A Biol Sci Med Sci, November 1, 2005; 60(11): 1386 - 1393. [Abstract] [Full Text] [PDF]

				K. Hardy, L. Mansfield, A. Mackay, S. Benvenuti, S. Ismail, P. Arora, M. J. O'Hare, and P. S. Jat Transcriptional Networks and Cellular Senescence in Human Mammary Fibroblasts Mol. Biol. Cell, February 1, 2005; 16(2): 943 - 953. [Abstract] [Full Text] [PDF]

				D. Kipling, T. Davis, E. L. Ostler, and R. G. A. Faragher What Can Progeroid Syndromes Tell Us About Human Aging? Science, September 3, 2004; 305(5689): 1426 - 1431. [Abstract] [Full Text] [PDF]

				K. J. Kyng, A. May, S. Kolvraa, and V. A. Bohr Gene expression profiling in Werner syndrome closely resembles that of normal aging PNAS, October 14, 2003; 100(21): 12259 - 12264. [Abstract] [Full Text] [PDF]

				R. J. Evans, F. S. Wyllie, D. Wynford-Thomas, D. Kipling, and C. J. Jones A P53-dependent, Telomere-independent Proliferative Life Span Barrier in Human Astrocytes Consistent with the Molecular Genetics of Glioma Development Cancer Res., August 15, 2003; 63(16): 4854 - 4861. [Abstract] [Full Text] [PDF]